Patients after kidney transplantation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with allogeneic kidney transplantation status; 2.Aged 18-80 years, both genders are acceptable; 3.The expected survival period before enrollment screening is more than 6 months; 4.All subjects were recruited voluntarily and signed the informed consent form, and were willing and able to comply with the study requirements for follow-up, treatment, examination, and to abide by the study requirements.
Exclusion criteria
Exclusion criteria: 1.Unable to conduct remote follow-up using smartphones; 2.Patients with a history of substance abuse and addiction or with mental disorders; 3.Patients whose accompanying diseases, as judged by the researchers, may seriously endanger the safety of the patients or prevent them from completing the study, and are considered unsuitable for participation; 4.Patients who have actively withdrawn from other clinical trials in the past or who may have the potential to do so.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of consistency between the AI-assisted diagnosis suggestions and the final decisions made by the clinicians; | — |
Secondary
| Measure | Time frame |
|---|---|
| Accuracy, Sensitivity, and Specificity;Follow up compliance rate of patients;Accuracy and positive predictive value;Satisfaction questionnaire score;Key clinical indicators; | — |
Countries
China
Contacts
Beijing Friendship Hospital ,Capital Medical University